A healthcare provider is educating a group of new parents about immunizations. The provider should instruct the parents that the series for which of the following vaccines is completed prior to the first birthday?

Questions 121

ATI RN

ATI RN Test Bank

ATI Pharmacology Questions

Question 1 of 5

A healthcare provider is educating a group of new parents about immunizations. The provider should instruct the parents that the series for which of the following vaccines is completed prior to the first birthday?

Correct Answer: D

Rationale: The correct answer is D, Rotavirus vaccine. The series for the Rotavirus vaccine is completed prior to the first birthday as it is only administered to infants less than 8 months of age. This vaccine provides protection against severe diarrhea and vomiting caused by rotavirus infection, which is common in infants and young children.

Question 2 of 5

A client with prostate cancer is receiving leuprolide. Which of the following findings should the nurse monitor?

Correct Answer: C

Rationale: The nurse should monitor the client for gynecomastia, as it is an adverse effect of leuprolide due to decreased testosterone levels. Leuprolide works by decreasing testosterone production, which can lead to gynecomastia, the development of male breast tissue. Monitoring for this side effect is essential for early detection and intervention.

Question 3 of 5

A client is starting therapy with bicalutamide. Which of the following adverse effects should the nurse instruct the client to monitor?

Correct Answer: C

Rationale: In this scenario, the correct answer is C) Gynecomastia. Bicalutamide is an androgen receptor antagonist commonly used in the treatment of prostate cancer. Gynecomastia, the development of breast tissue in males, is a well-known adverse effect of bicalutamide due to its anti-androgenic properties. It is crucial for the nurse to educate the client on monitoring for signs of gynecomastia to ensure early detection and intervention. Muscle pain (option A) is not typically associated with bicalutamide use and is therefore not a priority adverse effect to monitor. Flushing (option B) is also not a common side effect of bicalutamide and is unlikely to occur. Hyperglycemia (option D) is not directly related to bicalutamide use and is more commonly associated with other medications or conditions. In an educational context, understanding the adverse effects of medications is essential for nurses to provide safe and effective care to their clients. By knowing the expected side effects of specific drugs, nurses can educate clients on what to monitor for and when to seek medical attention. This knowledge enhances patient safety and promotes better outcomes in pharmacological therapy.

Question 4 of 5

When starting therapy with trastuzumab, which finding should the nurse instruct the client to report?

Correct Answer: A

Rationale: In pharmacology, understanding the side effects and adverse reactions of medications is crucial for safe and effective patient care. When starting therapy with trastuzumab, a monoclonal antibody used to treat certain types of cancer, the nurse should instruct the client to report dyspnea immediately. Dyspnea can be a sign of a serious side effect called cardiomyopathy, which is a known risk associated with trastuzumab therapy. Cardiomyopathy can lead to potentially life-threatening complications if not addressed promptly. The other options (B) Constipation, (C) Tinnitus, and (D) Dry mouth are less concerning side effects compared to dyspnea when starting trastuzumab therapy. Constipation is a common gastrointestinal side effect, tinnitus is not typically associated with trastuzumab, and dry mouth is a minor side effect that does not pose immediate serious risks to the client's health. Educationally, this question highlights the importance of recognizing and prioritizing potential side effects of medications to ensure patient safety. Nurses need to be vigilant in educating clients about signs and symptoms that warrant immediate attention to prevent serious complications and promote positive treatment outcomes.

Question 5 of 5

A client is receiving treatment with irinotecan. Which of the following findings should the nurse monitor?

Correct Answer: A

Rationale: In the context of a client receiving treatment with irinotecan, monitoring for diarrhea is crucial due to the common side effect of irinotecan-induced severe diarrhea. This adverse effect can lead to dehydration, electrolyte imbalances, and potential complications if not managed promptly. Therefore, Option A, diarrhea, is the correct answer that the nurse should monitor. Hypertension (Option B) is not a typical side effect associated with irinotecan therapy. Ototoxicity (Option C) is more commonly linked to certain antibiotics and chemotherapeutic agents like cisplatin, not irinotecan. Neutropenia (Option D) is a potential side effect of many chemotherapy drugs, but it is not specifically associated with irinotecan. Educationally, understanding the side effects of specific medications is crucial for nurses to provide safe and effective care to their patients. Monitoring for and recognizing common adverse effects of chemotherapy drugs like irinotecan can help prevent complications and improve patient outcomes. Nurses need to be knowledgeable about the expected side effects of medications to provide comprehensive care and timely interventions.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions